Cytogenetic and molecular characteristics of 25 Chilean patients with a variant Ph translocation

Kolomietz, 2001, Primary chromosomal rearrangements of leukemia are frequently accompained by extensive submicroscopic deletions and may lead to altered prognosis, Blood, 97, 3581, 10.1182/blood.V97.11.3581 Morel, 2003, Deletion of the 5′ abl region in Philadelphia chromosome-positive chronic myeloid leukemia, Leukemia, 17, 473, 10.1038/sj.leu.2402816 Reid, 2003, Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukemia, Br J Haematol, 121, 419, 10.1046/j.1365-2141.2003.04291.x Sinclair, 2000, Large deletions at the t(9;22) breakpoint are common and may identify a poor prognosis subgroup of patients with chronic myeloid leukemia, Blood, 95, 738, 10.1182/blood.V95.3.738.003k21_738_743 Fournier, 2005, Deletions of the 3′ BCR and 5′ ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells, Cancer Genet Cytogenet, 160, 184, 10.1016/j.cancergencyto.2005.01.002 Valencia, 2009, Complex variant t(9;22) chromosome translocations in five cases of chronic myeloid leukemia, Adv Hematology, 1, 10.1155/2009/187125 Godley, 2009, Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues, Leukemia & Lymphoma, 50, 871, 10.1080/10428190902980889 Castagnetti, 2010, Deletions of the derivative chromosome 9 do not Influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party Analysis, J Clin Oncol, 28, 2748, 10.1200/JCO.2009.26.7963 Dewald, 2000, A multicenter investigation with D-FISH BCR/ABL1 probes, Cancer Genet Cytogenet, 116, 97, 10.1016/S0165-4608(99)00120-X Johansson, 2002, Cytogenetics and molecular genetic evolution of chronic myeloid leukemia, Acta Hematol, 107, 76, 10.1159/000046636